S&P 500
(0.16%) 5 469.46 points
Dow Jones
(0.10%) 39 158 points
Nasdaq
(0.59%) 17 838 points
Oil
(2.12%) $83.27
Gas
(-3.88%) $2.50
Gold
(0.00%) $2 339.50
Silver
(0.14%) $29.60
Platinum
(-1.23%) $989.60
USD/EUR
(-0.12%) $0.932
USD/NOK
(-0.05%) $10.67
USD/GBP
(0.07%) $0.791
USD/RUB
(1.04%) $86.62

リアルタイムの更新: Bio-Rad Laboratories, [BIO-B]

取引所: NYSE セクター: Healthcare 産業: Medical - Devices
最終更新日時14 6月 2024 @ 03:22

0.00% $ 283.45

Live Chart Being Loaded With Signals

Commentary (14 6月 2024 @ 03:22):
No signals from the correlation tool
Profile picture for Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America...

Stats
本日の出来高 3
平均出来高 58
時価総額 8.04B
EPS $13.46 ( Q1 | 2024-05-08 )
次の収益日 ( $0 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -26.52
(Sector) 49.64
(Industry) 37.79
ATR14 $0 (0.00%)
ABT -0.93%
ALUR 0.74%
AORT -1.48%
AVNS -1.76%
BFLY 1.11%
BFLY-WT -20.85%
BIO -2.83%
BIO-B 0.00%
BSX -0.88%
BSX-PA 2.37%
CATX 5.22%
CNMD -2.70%
CRY 1.42%
EW -2.26%
FNA -2.34%
GKOS -1.38%
GMED -0.41%
INSP 0.84%
ITGR -0.49%
MDT -1.75%
NVRO 0.83%
OWLT -0.73%
PEN -2.43%
PHG -0.24%
RBOT -9.71%
SNN -0.85%
SONX 0.00%
STE -0.70%
SYK -1.27%
VAPO 0.48%
ZBH -2.16%
Insider Trading
Date Person Action Amount type
2023-12-16 Wright Dara Buy 502 Bio-Rad A Common Stock
2023-12-16 Wright Dara Sell 174 Bio-Rad A Common Stock
2023-12-16 Wright Dara Sell 502 Restricted Stock Units
2023-12-05 Schwartz Steven D Buy 49 Bio-Rad B Common Stock
2023-12-05 Schwartz Steven D Buy 49 Bio-Rad B Common Stock
INSIDER POWER
-17.63
Last 100 transactions
Buy: 98 565 | Sell: 137 343
相関 (AI algo v.1.1b): Paired value (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

Bio-Rad Laboratories, 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bio-Rad Laboratories, 財務諸表

Annual 2023
収益: $2.67B
総利益: $1.43B (53.58 %)
EPS: $-21.82
FY 2023
収益: $2.67B
総利益: $1.43B (53.58 %)
EPS: $-21.82
FY 2022
収益: $2.80B
総利益: $1.57B (55.93 %)
EPS: $-121.79
FY 2021
収益: $2.92B
総利益: $1.64B (56.14 %)
EPS: $142.63

Financial Reports:

No articles found.

Bio-Rad Laboratories, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Bio-Rad Laboratories,

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians\' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 1.9157202243805 seconds
Number of API calls: 3
Number of DB calls: 9